Pilar G. Diz - Publications

Immunogenicity of COVID-19 vaccines in lung cancer patients.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: July 21, 2023

Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: results from the Spanish early access program.

Journal: Oncotarget

Published: April 08, 2022

SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 20, 2022

Lung cancer patients with COVID-19 in Spain: GRAVID study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 16, 2021

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.

Journal: BMC cancer

Published: September 20, 2020

Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial.

Journal: Molecular oncology

Published: June 28, 2020

ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort.

Journal: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia

Published: July 23, 2019

Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.

Journal: The Journal of urology

Published: June 05, 2019

SEOM clinical guidelines on nutrition in cancer patients (2018).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 03, 2018

Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 31, 2018

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 22, 2017

Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.

Journal: BMC cancer

Published: June 20, 2016